Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platform which will target the Omicron variant, the strain that is driving the…
WASHINGTON: Pfizer on Wednesday asked the US to authorize extra-low doses of its Covid-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start…
Vaccine major Serum Institute of India (SII) on Tuesday said the approval for the COVID-19 vaccine ‘Covovax’ would strengthen immunization initiatives across India and various lower and middle income countries…
British regulators on Wednesday approved Pfizer’s Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time…
NBA leadership made the decision that games will go on based on one driving factor: science. While the NFL shifted testing protocol and the NHL paused games until Monday, commissioner…
Geneva: Covovax, produced by Serum Institute of India (SII) under the license from Novovax, became the ninth COVID-19 vaccine to receive Emergency Use Listing (EUL) from the World Health Organisation…
CALIFORNIA: Researchers have found rare naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses. The study has been published…
India is not considering authorising booster COVID-19 doses yet as many in the country have been naturally infected and the government believes two doses of a vaccine offers sufficient protection…
BENGALURU: An indigenous drone developed by National Aerospace Laboratories (NAL), a lab of the Council of Scientific and Industrial Research (CSIR), was used to deliver Covid-19 vaccine from one primary…
AP Photo/Lynne Sladky Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of…
